Dr. Hicks' first research interest was in bone pathology. He received NIH funding to study the effects of lead on the epiphyseal plate, and collaborated on related studies with faculty in the Department of Orthopaedics at the University of Rochester. He published extensively on metabolic and neoplastic bone disorders. While Director of Surgical Pathology and Co-director of the Morphologic Molecular Pathology translation research resource at the Cleveland Clinic, he expanded his interests in breast pathology, with particular focus on prognostic molecular markers and development of advanced tissue-based diagnostic techniques.
His current clinical translational research interests focus on molecular risk factors for breast cancer and preanalytical variables that affect the accuracy of new diagnostic technology in surgical pathology.
Wang X, El-Halaby AA, Zhang H, Yang Q, Laughlin TS, Rothberg PG, Skinner K, Hicks DG. "P53 alteration in morphologically normal/benign breast luminal cells in BRCA carriers with or without history of breast cancer." Human pathology.. 2017 Apr 21; Epub 2017 Apr 21.
Turner BM, Hicks DG. "Pathologic diagnosis of breast cancer patients: evolution of the traditional clinical-pathologic paradigm toward "precision" cancer therapy." Biotechnic & histochemistry : official publication of the Biological Stain Commission.. 2017 92(3):175-200. Epub 2017 Mar 20.
Kim HS, Umbricht CB, Illei PB, Cimino-Mathews A, Cho S, Chowdhury N, Figueroa-Magalhaes MC, Pesce C, Jeter SC, Mylander C, Rosman M, Tafra L, Turner BM, Hicks DG, Jensen TA, Miller DV, Armstrong DK, Connolly RM, Fetting JH, Miller RS, Park BH, Stearns V, Visvanathan K, Wolff AC, Cope L. "Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2016 Dec 20; 34(36):4390-4397. Epub 2016 Oct 31.
View All Publications